本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿爾尼拉姆製藥公司

248.68
+1.170.47%
盤後250.001.32+0.53%19:30 EDT
成交量:117.74萬
成交額:2.95億
市值:331.81億
市盈率:44.25
高:254.08
開:248.05
低:246.01
收:247.51
52周最高:495.55
52周最低:197.81
股本:1.33億
流通股本:1.33億
量比:0.72
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):5.62
每股收益(LYR):2.33
淨資產收益率:96.55%
總資產收益率:12.34%
市淨率:24.50
市盈率(LYR):106.73

資料載入中...

2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/08/22

SEC問詢函

Form CORRESP - Correspondence
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities